If in 2021 IPIX can get BRILACIDIN fully FDA approved and marketed then I AGREE 2022 could be the YEAR for KEVETRIN which I still regard as the bigger of the two in the long run for IPIX
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
